ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics.  ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA.  ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases.  We are well-financed by a syndicate of renowned VC firms. 

ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.  

Lilly Asia Ventures

OrbiMed

Sirona Capital

SR One

Ascenta Capital

Vivo Capital

BlackRock

Bain Capital Life Sciences

Cormorant Asset Management

Redmile Group

Marshall Wace

HBM Healthcare Investments AG

T. Rowe Price

Venrock Healthcare Capital Partners

ADARx Pharmaceuticals Inc.

Adarx is a technology company that specializes in developing advanced data analytics and artificial intelligence solutions for healthcare and life sciences. Their platform aims to accelerate drug discovery and development by providing insights through data integration, machine learning, and predictive modeling.

Adarx

COM:ADARX

Adarx

Filings Not Available